NASDAQ: CSTL - Castle Biosciences, Inc.

Yield per half year: +74.38%
Sector: Healthcare

Current price
21.59 $
Average price
8.33 $ -61.44%

Price based on EPS
23.68 $ +9.67%
3.33/10

Price based on EPS

Price = Price * (100 - CAGR EPS * Excess Key Rate) / 100
Key Rate = Key rate
Fair price = 23.68 $
Current price = 21.59 $ (difference = +9.67%)


Data

Discounted Cash Flow (Based EBITDA)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount Ebitda(5) * (1 + Ebitda Yield) / (WACC - Ebitda Yield)
Company Value = ∑ (Future Ebitda / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 1.08 $
Current price = 21.59 $ (difference = -94.99%)


Data

Discounted Cash Flow (Based FCF)

Price = (Terminal Value + Company Value) / Count shares
Price - Fair price
Terminal Value — cost in the post-forecast period
Company Value — cost during the forecast period
Count shares - Number of shares
Terminal Value = Discount FCF(5) * (1 + FCF Yield) / (WACC - FCF Yield) ^ 5
Company Value = ∑ (FCF / (1 + WACC) ^ 5)
WACC - weighted average cost of capital (taking into account country risks, inflation, taxes, etc.)
Fair price = 0.2183 $
Current price = 21.59 $ (difference = -98.99%)


Data

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription